Indeed, COX-2 upregulation and/or abnormal expression have been reported in several types of cancer [5]–[8] and elevated COX-2 expression in tumors is associated with increased angiogenesis, tumor invasion and resistance to apoptosis. This evidence concerns the gene PTGS2 and neoplasm.